Dianthus Therapeutics, Inc.DNTHNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P33
Within normal range
vs 5Y Ago
-3.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-64.71%
202469.82%
2023-11.18%
2022-98.95%
202186.01%
202017.72%
2019-20.13%
2018-72.09%
2017-275.88%
20160.00%